Drug-coated stents that prop open the arteries of about 3 million people in the U.S. don't increase the risk of heart attack or death when used as labeled but may put patients at risk for blood clots, says the FDA.
In an earth shaking development, Johnson & Johnson - a stent maker - said there is no significant difference in clotting, heart attack or death rates between its stent, the Cypher, and bare metal versions.
You can read more here.
